Stock Code: 002772 stock abbreviation: Tianshui Zhongxing Bio-Technology Co.Ltd(002772) Announcement No.: 2022-012 bond Code: 128026 bond abbreviation: Zhongxing convertible bonds
Tianshui Zhongxing Bio-Technology Co.Ltd(002772)
Announcement of resolutions of the 11th meeting of the 4th board of directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of directors
The 11th meeting of the 4th board of directors of Tianshui Zhongxing Bio-Technology Co.Ltd(002772) (hereinafter referred to as “the company”) was held by means of communication in the company conference room of Tianshui national agricultural science and Technology Park on February 17, 2022. The meeting was presided over by Mr. Gao boshu, chairman of the company. The notice of the meeting was sent to all directors and senior managers by e-mail on February 14, 2022. There are 9 directors who should attend the meeting, and 9 actually attended the meeting. The company’s supervisors, senior managers and the Secretary of the board of directors attended the meeting as nonvoting delegates. The convening and convening of this meeting comply with the relevant provisions of the company law and other laws and regulations and the articles of association.
2、 Deliberations of the board meeting
After careful deliberation by the directors attending the meeting, the following proposals were adopted by open ballot at the meeting: (I) the proposal on Amending the entrusted financial management system was considered and adopted
In order to further improve the management of the company’s entrusted wealth management business, prevent investment risks, and protect the rights and interests of investors and the company, the company, in accordance with the securities law, the stock listing rules of Shenzhen Stock Exchange and the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board The company has revised the entrusted financial management system in combination with the actual situation of the company, in accordance with the provisions of relevant laws and regulations, normative documents and the articles of association, such as the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 7 – transactions and related party transactions.
Voting: 9 in favor, 0 against, 0 abstention and 0 withdrawal
Voting result: adopted
The revised entrusted financial management system is detailed in cninfo.com, the information disclosure media designated by the company（ http://www.cn.info.com.cn. ）。
(II) the proposal on Amending the investor relations management system was deliberated and adopted
In order to further standardize the management of investor relations, establish a good communication relationship of timely and mutual trust between the company and investors, improve corporate governance and promote the high-quality development of the company, according to the company law, the securities law and the stock listing rules of Shenzhen Stock Exchange The company revised the investor relations management system in combination with the actual situation of the company in accordance with the provisions of relevant laws and regulations, normative documents and the articles of association, such as the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board.
Voting: 9 in favor, 0 against, 0 abstention and 0 withdrawal
Voting result: adopted
The revised investor relations management system is detailed in cninfo.com, the information disclosure media designated by the company（ http://www.cn.info.com.cn. ）。
3、 Documents for future reference
Resolution of the 11th meeting of the Tianshui Zhongxing Bio-Technology Co.Ltd(002772) 4th board of directors
It is hereby announced
Tianshui Zhongxing Bio-Technology Co.Ltd(002772) board of directors February 17, 2022
